Acute fatty liver of pregnancy (AFLP) is a rare obstetric complication, and despite improvements in recognition and management over recent decades, it still carries a high risk of maternal and fetal ...
At the moment, there is a lack of clinically relevant preclinical models for fatty liver disease. This problem has led to most drug candidates that were successful in preclinical development ...
Nonalcoholic fatty liver disease (NAFLD) and its progressive form, nonalcoholic steatohepatitis (NASH) are the most common causes of chronic liver disease in industrialized countries. NAFLD has ...
Metabolic dysfunction-associated steatotic liver disease (MASLD) — previously known as “non-alcoholic fatty liver disease” — affects about 25% of the global population. Its severe form, metabolic ...
£35 means we can empower more people living with HIV to challenge stigma with our information workshops, videos and broadcasts. Fatty liver disease occurs when fat builds up in liver cells. A healthy ...
Fatty liver disease, also called steatotic liver disease, occurs when excess fat builds up in the liver, leading to inflammation and potential liver damage. Risk factors include obesity ...
MASLD, which was known until recently as nonalcoholic fatty liver disease, is estimated to affect nearly 4 in 10 people worldwide. It is the fastest-growing reason that people require liver ...